News and Announcements
TokenOne Selected by US National Cybersecurity Centre of Excellence for Multi-Factor Authentication
- Published August 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Australian cyber security company TokenOne has become the first local business selected by the United States National Cybersecurity Centre of Excellence and will work with association to tackle identity theft and fraud in e-commerce through multi-factor authentication.
KEY TAKEAWAYS:
- The company has developed authentication technology that has eliminated traditional passwords by utilising one-time pad principals, to create unique, unbreakable codes.
- A crypto algorithm in which plaintext is combined with a random key.
- TokenOne chief executive Phil Cuff said the roots of its authentication technology had existed since World War II.
“The spies and spooks have used these ciphers for decades to communicate,” he said. “It’s the only universally accepted form of uncrackable encryption and so we applied this concept to authentication and instead of messages applied it to an app on a user’s smartphone.”
“The problem with passwords is we all have too many of them, so we write them down, or tell someone else,” Mr Cuff said.
“From a market perspective, we operate through a distributor in Australia and their resellers and we want to continue to do that here and overseas. We want to go from thousands and tens of thousands of users to millions and what we really want to do is get rid of 100 billion passwords.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
